Comparative effect of two pan-class I PI3K inhibitors used as anticancer drugs on human T cell function-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative effect of two pan-class I PI3K inhibitors used as anticancer drugs on human T cell function

Published:2015-09 Issue:1 Volume:28 Page:675-685
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Blanco Belén,Herrero-Sánchez Carmen,Rodríguez-Serrano Concepción,Sánchez-Barba Mercedes,del Cañizo María Consuelo

Funder

Fundación Científica de la Asociación Española Contra el Cáncer Ayudas a Investigadores en Oncología 2011

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference57 articles.

1. Regulation of phosphoinositide 3-kinase expression in health and disease;Kok;Trends Biochem. Sci.,2009

2. Oncogenic PI3K and its role in cancer;Samuels;Curr. Opin. Oncol.,2006

3. The mutational landscape of head and neck squamous cell carcinoma;Stransky;Science,2011

4. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1;Agrawal;Science,2011

5. Frequent mutation of the PIK3CA gene in ovarian and breast cancers;Levine;Clin. Cancer Res.,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in PI3 Kinase Inhibitors: Anticancer Activities and Structure-Activity Relationships;Mini-Reviews in Medicinal Chemistry;2022-09

2. Research update on the anticancer effects of buparlisib (Review);Oncology Letters;2021-02-09

3. The immunomodulatory effects of endocrine therapy in breast cancer;Journal of Experimental & Clinical Cancer Research;2021-01-07

4. Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma;Clinical Cancer Research;2018-12-06

5. Potential anti-cancer activity of 7- O -pentyl quercetin: Efficient, membrane-targeted kinase inhibition and pro-oxidant effect;Pharmacological Research;2017-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3